4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0000899243-22-030186
Chief Executive Officer gave up 18,750 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Kevin S. Sr. Chief Executive Officer | 2022-08-30 | Shares withheld for taxes | −18,750 | $2.41 | $45,188 | 866,250 | D |
Loading xslF345X03/doc4.xml…